Acute pulmonary hypertension as a symptom of Bard’s syndrome and pulmonary lymphangitis carcinomatosa – rare manifestation of malignant gastric cancer
DOI:
https://doi.org/10.15584/ejcem.2019.2.13Keywords:
Bard’s syndrome, malignant gastric cancer, pulmonary hypertensionAbstract
Introduction. Acute pulmonary hypertension leading to right ventricular failure and circulatory collapse is usually caused by a pulmonary embolism. However, in extremely rare cases, similar clinical manifestations can be related to another diseases, such as lymphangitis carcinomatosa.
Aim. The purpose of this paper is to report on the case of a 29-year-old male patient presented with rapidly progressing dyspnoea.
Description of the case. The diagnosis of pulmonary embolism was made on the basis of echocardiographic signs of pulmonary hypertension and right ventricular (RV) dilatation, and the recommended therapy was introduced. On the suspicion of bronchopneumonia, antibiotics and steroids were applied. However, the previously stated diagnosis of pulmonary embolism was not confirmed by the angio-CT scan, which showed small diffusive lung parenchyma intra-biliary nodules (ground glass opacity) with the peripheral appearance of a tree-in-bud sign. Consecutive CT of pelvis and abdomen along with endoscopy revealed a metastatic gastric cancer with the presence of lymphangitis carcinomatosa and miliary dissemination to the lungs. The presence of pulmonary metastases in the course of disseminated gastric cancer is known in literature as Bard’s syndrome.
Conclusion. Extrapulmonary malignancies, particularly gastric cancer, should be taken into consideration in differential diagnosis in patients with an acute right ventricular failure and nonspecific lesions in the respiratory system.
Downloads
References
Harjola VP, Mebazaa A, Celutkien J, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail. 2016;18(3):226-241.
Konstantinides S, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033-69;3069a-3069k.
Galie N, Humbert M, Vachieryc J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2016;37,67–119.
Grünig E, Peacock A.J. Imaging the heart in pulmonary hypertension: an update. Eur Respir Rev. 2015;24(138):653-664.
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2018;68:394-424.
Samson M, Vachon M, Brochu J, Tremblay P. Bard's syndrome. Pulmonary miliary carcinomatosis secondary to a gastric neoplasm. Laval Med. 1962;33:106-110.
Zieliński M, Ochman M, Głowacki J, Kozielski J. Pulmonary lesions in the course of gastric cancer--two cases of Bard's syndrome. Pneumonol Alergol Pol. 2016;84(1):33-37.
Bruce DM, Heys SD, Eremin O. Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb. 1996;41(1):7-13.
Bhattacharya PK, Khonglah JY, Roy A, Subrahmanya MV. A rare case of pulmonary lymphangitic carcinomatosis in a young adult with carcinoma stomach. J Clin Diagn. 2017;8:OD07-OD09.
Witczak A, Prystupa A, Zamecka MO, Bilan A, Krupski W, Mosiewicz J. Pulmonary lymphangitic carcinomatosis in the course of gastric cancer-Case report. Journal of Pre-Clinical and Clinical Research. 2014;8(2):116-119.
Zhuang L, Liu X, Hu C, et al. Pulmonary lymphangitic carcinomatosis in liver carcinoma: a rare case report and literature. World Journal of Surgical Oncology. 2014;12:66.
Moubax K, Wuyts W, Vandecaveye V, Prenen H. Pulmonary lymphangitic carcinomatosis as a primary manifestation of gastric carcinoma in a young adult: a case report and review of the literature. BMC Research Notes. 2012;5:638.
Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219-225.
Piessen G, Messager M, Leteurtre E, Jean-Pierre T, Mariette C. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg. 2009;250(6):878-887.
Bagnato G, Harari S. Cellular interactions in the pathogenesis of interstitial lung diseases. Eur Respir Rev. 2015;24:102-114.
Mury C, Schneider AG, Nobile A, Rotman S, Liaudet L. Acute pulmonary hypertension caused by tumor embolism: a report of two cases. Pulm Circ. 2015;5(3):577-579.
Schriner R, Ryu J, Edwards W. Microscopic Pulmonary Tumor Embolism Causing Subacute Cor Pulmonale: A Difficult Antemortem Diagnosis. Mayo Clin Proc. 1991;66:143-148.
Hyung Kang S, Seok Kim J, Seok Moon H, et al. Signet ring cell carcinoma of early gastric cancer, is endoscopic treatment really risky? Medicine Baltimore. 2017;96(33):e7532.
Gilchrist F.J, Alton H, Brundler M.A, Edwards L, Plunkett, S.A. Pulmonary lymphangitic carcinomatosis presenting as severe interstitial lung disease in a 15-year-old female. Eur Respir Rev. 2011;20(121):208-210.
Kikuchi N, Shiozawa T, Ishii Y, et al. A patient with pulmonary lymphangitic carcinomatosis successfully treated with TS-1 and cisplatin. Intern Med. 2007;46:491-494.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
